Penka Kovacheva

Principal

Contact

  • Los Angeles

Education

Penka Kovacheva specializes in litigation and regulatory investigations within the life sciences and healthcare industries. She works closely with academic experts and attorneys, and leads large teams in performing complex economic and statistical analyses on a range of issues within these industries. In particular, Dr. Kovacheva has extensive experience in:

Antitrust litigation and merger investigations
  • Investigated allegations of anticompetitive delay of generic entry
  • Analyzed allegations of price fixing among generic drug manufacturers
  • Examined class certification issues in end-payor and direct purchaser class actions
  • Estimated competitive effects of a vertical merger between a health insurer and a pharmacy benefit manager
Statistical sampling matters
  • Performed statistical sampling and evaluated sample designs and extrapolation methods to address allegations of Medicare and Medicaid overpayment for healthcare services
  • Assessed the use of sampling to establish liability and damages in False Claims Act matters and government audits of healthcare providers
Intellectual property disputes
  • Analyzed indicators of commercial success and nexus to patent claims in Hatch-Waxman disputes
  • Assessed potential irreparable harm in the context of preliminary injunction motions
Press Release

Cornerstone Research Promotes Seven to Vice President and Principal

Case

Cigna’s Acquisition of Express Scripts

Case

Sampling In FCA Litigation

Case

Commercial Success

Case

Irreparable Harm

  •  Women@ Initiative for “Up-And-Coming” Women Competition Professionals, 17 June 2019
  • “Spikes in Drug Prices: Outrageous or Legitimate?,” Health Care and Pharmaceuticals Committee, American Bar Association Section of Antitrust Law, 29 June 2017